New Black Book poll of 118 health plan IT professionals finds data sharing success now depends on provider engagement and EHR vendor alignment. CHICAGO, IL / ACCESS Newswire / October 23, 2025 / A ...
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 23, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into ...
The Next Generation of Post-Workout and Everyday Wellness Apparel BOSTON, MA / ACCESS Newswire / October 23, 2025 / Skineez®, a women-owned, U.S.-made, tariff free wellness brand and pioneer in ...
Dr. Paredes' practice is celebrated for its rapid growth, patient-centered approach, and service to the Coachella community COACHELLA, CA / ACCESS Newswire / October 23, 2025 / Desert Oasis Healthcare ...
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers ...
Former DEA policy chief Matthew Strait , after stalling America's medical cannabis manufacturing program for years, rebrands himself as a "consultant" - selling advice on how to navigate the very ...
Brilliance 2025 - themed "Celebrating Women Disrupting Healthcare" - brings together executives, physicians, and entrepreneurs to share bold strategies for leading change, fostering inclusion, and ...
New Florida stem cell law provides ZEO with new pathways to market and sell regenerative therapy products and advance clinical research initiatives FORT LAUDERDALE, FL / ACCESS Newswire / October 23, ...
NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer screening, has teamed up with Laurel Bridge Software, a leader in ...
NAPLES, FL / ACCESS Newswire / October 23, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture ...
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that ...
Novartis reports that Fabhalta® achieved the Phase III APPLAUSE-IgAN primary endpoint, showing slowed kidney-function decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback